PPH - (VanEck Vectors Pharmaceutical ETF)

PPHのニュース

   Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis  2022/04/22 12:30:00 Kwhen Finance
   Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis  2022/01/26 16:30:00 Kwhen Finance
   Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis  2022/04/22 12:30:00 Kwhen Finance
   Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis  2022/01/26 16:30:00 Kwhen Finance
   Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis  2022/04/22 12:30:00 Kwhen Finance
   Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis  2022/01/26 16:30:00 Kwhen Finance

calendar